Biotechnology And Pharmaceutical Services Outsourcing Global Market Report 2025
상품코드:1810840
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
바이오테크놀러지 및 제약 서비스 아웃소싱 시장 규모는 향후 몇 년 동안 강력한 성장이 예상됩니다. 2029년에는 CAGR 7.2%로 949억 1,000만 달러로 성장할 것입니다. 예측 기간 동안 예상되는 성장은 의약품 승인 신속화에 대한 압력 증가, 임상 연구 활동의 세계화, 세계 임상시험량 증가, 임상 1상부터 4상 시험의 아웃소싱 증가, 적응증 시험 및 분산형 시험에 대한 집중도 강화에 기인할 것으로 보입니다. 이 기간 동안 주요 동향으로는 실시간 협업을 위한 클라우드 기반 플랫폼의 도입, 신약개발에 AI와 머신러닝의 활용, 바이오인포매틱스 및 데이터 분석의 발전, 실험실 서비스에 자동화와 로봇공학의 통합, 전자 데이터 수집 시스템의 보급 등이 있습니다. 보급 등을 들 수 있습니다.
임상연구의 활성화가 조사 시장의 성장을 견인할 것으로 예상됩니다. 임상연구는 건강상태에 대한 이해를 높이고 치료의 안전성과 유효성을 평가하기 위해 인간을 대상으로 체계적인 연구를 진행합니다. 이러한 연구 활동의 성장은 주로 만성질환의 부담 증가로 인해 환자 치료를 개선하기 위한 새로운 치료법의 개발 및 평가가 요구되고 있기 때문입니다. 바이오테크놀러지 및 제약 서비스 아웃소싱은 전문 지식과 첨단 인프라에 대한 액세스를 제공함으로써 임상 연구를 촉진하고, 효율적이고 비용 효율적이며 규정을 준수하는 임상시험을 전 세계적으로 수행할 수 있도록 지원합니다. 예를 들어, 영국에 기반을 둔 업계 단체인 영국제약산업협회(Association of the British Pharmaceutical Industry)는 2023년 11월 영국에서 업계 주도의 임상시험 건수가 2021년 394건에서 2022년 411건으로 4.3% 증가했다고 보고했습니다.% 증가했다고 보고했습니다. 이러한 증가는 임상 개발의 외부 위탁 지원에 대한 수요가 증가하고 있음을 보여줍니다.
바이오테크놀러지 및 제약 서비스 아웃소싱 시장의 주요 기업들은 원격 액세스 및 실시간 협업을 지원하는 클라우드 기반 플랫폼과 같은 고급 툴을 개발하고 있습니다. 이러한 플랫폼은 인터넷 기반 시스템이며, 로컬 인프라에 의존하지 않고 스토리지, 소프트웨어, 처리 기능 등의 컴퓨팅 리소스에 대한 원격 액세스를 사용자에게 제공합니다. 예를 들어, 미국에 본사를 둔 비임상시험 수탁기관인 Charles River Labs는 2023년 3월 독성학 연구 강화를 목적으로 하는 클라우드 기반 플랫폼 Apollo를 발표했습니다. 이 플랫폼은 안전성 및 독성 평가를 위한 시험 데이터에 대한 접근을 용이하게함으로써 고객 경험을 향상시킵니다. 이 플랫폼은 사용자가 시험 진행 상황을 추적하고, 데이터를 검토하고, 중요한 문서에 단독으로 액세스할 수 있는 셀프서비스 옵션을 제공합니다. 특히, 보다 정확하고 효율적인 예산 계획을 지원하는 견적 기능도 포함되어 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 바이오테크놀러지 및 제약 서비스 아웃소싱 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업 분석
세계의 바이오테크놀러지 및 제약 서비스 아웃소싱 시장 : 성장률 분석
세계의 바이오테크놀러지 및 제약 서비스 아웃소싱 시장 실적 : 규모와 성장, 2019-2024
세계의 바이오테크놀러지 및 제약 서비스 아웃소싱 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계의 바이오테크놀러지 및 제약 서비스 아웃소싱 : 총 잠재 시장 규모(TAM)
제6장 시장 세분화
세계의 바이오테크놀러지 및 제약 서비스 아웃소싱 시장 : 서비스별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
컨설팅
규제 관련 업무
제품 설계와 개발
감사와 평가
제품 유지보수
트레이닝과 교육
기타 서비스
세계의 바이오테크놀러지 및 제약 서비스 아웃소싱 시장 : 용도별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
종양학
신경학
심혈관계
감염증
세계의 바이오테크놀러지 및 제약 서비스 아웃소싱 시장 : 최종 용도별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제약
바이오테크놀러지
세계의 바이오테크놀러지 및 제약 서비스 아웃소싱 시장 : 하위 세분화 컨설팅(종류별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
전략 컨설팅
시장 접근 컨설팅
상업화 전략
포트폴리오 관리
테크놀러지와 디지털 변혁 컨설팅
세계의 바이오테크놀러지 및 제약 서비스 아웃소싱 시장 : 하위 세분화 규제 관련 업무(종류별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
규제 당국에의 제출
컴플라이언스와 리스크 관리
제품 등록
라벨과 패키지 검토
규제 정보
세계의 바이오테크놀러지 및 제약 서비스 아웃소싱 시장 : 하위 세분화 제품 설계·개발(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
처방 개발
전임상 개발
바이오프로세스 개발
분석 개발
약물전달 시스템 설계
세계의 바이오테크놀러지 및 제약 서비스 아웃소싱 시장 : 하위 세분화 감사와 평가(종류별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
적정 제조 규범(GMP) 감사
적정 임상시험 기준(GCP) 감사
품질 시스템 감사
공급업체 및 벤더 감사
리스크 평가
세계의 바이오테크놀러지 및 제약 서비스 아웃소싱 시장 : 하위 세분화 제품 유지보수(종류별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
수명주기 관리
변경 관리
기술 지원
소프트웨어와 IT 시스템 업데이트
컴플라이언스 감시
세계의 바이오테크놀러지 및 제약 서비스 아웃소싱 시장 : 하위 세분화 연수와 교육(종류별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
규제 연수
우량 시험기관 기준(GLP) 트레이닝
의약품 안전성 감시 트레이닝
임상시험 트레이닝
품질 관리 시스템 연수
세계의 바이오테크놀러지 및 제약 서비스 아웃소싱 시장 : 하위 세분화 기타 서비스(종류별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
지적재산 서포트
메디컬 라이팅
데이터 관리와 생물 통계학
의약품 안전성 감시와 의약품 안전성
번역 및 로컬라이제이션 서비스
제7장 지역별·국가별 분석
세계의 바이오테크놀러지 및 제약 서비스 아웃소싱 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 바이오테크놀러지 및 제약 서비스 아웃소싱 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
바이오테크놀러지 및 제약 서비스 아웃소싱 시장 : 경쟁 구도
바이오테크놀러지 및 제약 서비스 아웃소싱 시장 : 기업 개요
Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
Boehringer Ingelheim Overview, Products and Services, Strategy and Financial Analysis
LabCorp Holdings Overview, Products and Services, Strategy and Financial Analysis
IQVIA Inc. Overview, Products and Services, Strategy and Financial Analysis
ICON plc. Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업과 혁신적 기업
Eurofins Scientific SE
Lonza Group Ltd.
Syneos Health
Catalent Inc.
Charles River Laboratories
Samsung Biologics Co. Ltd.
WuXi Biologics
Recipharm AB
Medpace Holdings Inc.
Curia Inc.
CordenPharma Corp.
Parexel International Ltd.
Lachman Consultants
Concept Heidelberg GmbH
The Quantic Group Ltd.
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
바이오테크놀러지 및 제약 서비스 아웃소싱 시장 2029 : 새로운 기회를 제공하는 국가
바이오테크놀러지 및 제약 서비스 아웃소싱 시장 2029 : 새로운 기회를 제공하는 부문
바이오테크놀러지 및 제약 서비스 아웃소싱 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁 전략
제36장 부록
KSM
영문 목차
영문목차
Biotechnology and pharmaceutical services outsourcing is the strategic practice where life sciences companies delegate specific functions or processes to third-party organizations. This approach allows companies to concentrate on their core competencies, enhance operational efficiency, and reduce costs by utilizing external expertise and infrastructure.
The primary services involved in biotechnology and pharmaceutical outsourcing include consulting, regulatory affairs, product design and development, auditing and assessment, product maintenance, training and education, and others. Consulting provides expert guidance on strategy, operations, compliance, and market entry. These services are applied across therapeutic areas such as oncology, neurology, cardiovascular, and infectious diseases and cater to end users including pharmaceutical and biotech companies.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.
The biotechnology and pharmaceutical services outsourcing market research report is one of a series of new reports from The Business Research Company that provides biotechnology and pharmaceutical services outsourcing market statistics, including biotechnology and pharmaceutical services outsourcing industry global market size, regional shares, competitors with a biotechnology and pharmaceutical services outsourcing market share, detailed biotechnology and pharmaceutical services outsourcing market segments, market trends and opportunities, and any further data you may need to thrive in the biotechnology and pharmaceutical services outsourcing industry. This biotechnology and pharmaceutical services outsourcing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The biotechnology and pharmaceutical services outsourcing market size has grown strongly in recent years. It will grow from $66.87 billion in 2024 to $71.87 billion in 2025 at a compound annual growth rate (CAGR) of 7.5%. The growth during the historic period can be attributed to the rising demand for therapeutic expertise and global trial design, an increasing number of orphan drug and rare disease trials, the growth of biologics and biosimilar development, greater utilization of laboratory testing and analytical services, and the expansion of virtual biotech firms.
The biotechnology and pharmaceutical services outsourcing market size is expected to see strong growth in the next few years. It will grow to $94.91 billion in 2029 at a compound annual growth rate (CAGR) of 7.2%. The growth expected in the forecast period can be attributed to increasing pressure for faster drug approvals, the globalization of clinical research activities, a rise in the volume of clinical trials worldwide, growing outsourcing of phase I-IV trials, and a stronger focus on adaptive and decentralized trials. Key trends during this period include the adoption of cloud-based platforms for real-time collaboration, the use of AI and machine learning in drug discovery and development, advancements in bioinformatics and data analytics, the integration of automation and robotics in laboratory services, and the widespread use of electronic data capture systems.
The increasing activity in clinical research is anticipated to drive the growth of the biotechnology and pharmaceutical services outsourcing market. Clinical research involves systematic investigations using human participants to better understand health conditions and assess the safety and efficacy of medical treatments. This growth in research activity is primarily due to the rising burden of chronic diseases, which calls for the development and evaluation of new therapeutic options to improve patient care. Outsourcing biotechnology and pharmaceutical services facilitates clinical research by offering access to specialized expertise and advanced infrastructure, enabling efficient, cost-effective, and regulatory-compliant trial execution on a global scale. For example, in November 2023, the Association of the British Pharmaceutical Industry, a UK-based trade group, reported a 4.3% rise in the number of industry-led clinical trials in the UK, from 394 in 2021 to 411 in 2022. This increase highlights the expanding demand for outsourced support in clinical development.
Leading companies in the biotechnology and pharmaceutical services outsourcing market are developing advanced tools like cloud-based platforms to support remote access and real-time collaboration. These platforms are internet-based systems that provide users with remote access to computing resources such as storage, software, and processing capabilities, without depending on local infrastructure. For instance, in March 2023, Charles River Labs, a US-based non-clinical contract research organization, introduced Apollo, a cloud-based platform aimed at enhancing toxicology studies. The platform improves client experience by enabling easier access to study data for safety and toxicology assessments. It features self-service options that let users track study progress, review data, and access important documents independently. Notably, it also includes a quoting feature to assist with more accurate and efficient budget planning.
In July 2024, IntegriChain, a software company based in the United States, acquired Federal Compliance Solutions (FCS) for an undisclosed amount. This acquisition strengthens IntegriChain's capabilities in commercialization, revenue operations, and government pricing. Federal Compliance Solutions is a US-based company specializing in outsourcing services for the biotechnology and pharmaceutical sectors.
Major players in the biotechnology and pharmaceutical services outsourcing market are Thermo Fisher Scientific Inc., Boehringer Ingelheim, LabCorp Holdings, IQVIA Inc., ICON plc., Eurofins Scientific SE, Lonza Group Ltd., Syneos Health, Catalent Inc., Charles River Laboratories, Samsung Biologics Co. Ltd., WuXi Biologics, Recipharm AB, Medpace Holdings Inc., Curia Inc., CordenPharma Corp., Parexel International Ltd., Lachman Consultants, Concept Heidelberg GmbH, The Quantic Group Ltd.
North America was the largest region in the biotechnology and pharmaceutical services outsourcing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in biotechnology and pharmaceutical services report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the biotechnology and pharmaceutical services Outsourcing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The biotechnology and pharmaceutical services outsourcing market includes revenues earned by entities by pharmacovigilance, medical writing, data management, analytical testing services, and formulation development. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Biotechnology And Pharmaceutical Services Outsourcing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on biotechnology and pharmaceutical services outsourcing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for biotechnology and pharmaceutical services outsourcing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The biotechnology and pharmaceutical services outsourcing market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Service: Consulting; Regulatory Affairs; Product Design And Development; Auditing And Assessment; Product Maintenance; Training And Education; Other Services
2) By Application: Oncology; Neurology; Cardiovascular; Infectious Diseases
3) By End-Use: Pharma; Biotech
Subsegments:
1) By Consulting: Strategic Consulting; Market Access Consulting; Commercialization Strategy; Portfolio Management; Technology And Digital Transformation Consulting
2) By Regulatory Affairs: Regulatory Submissions; Compliance And Risk Management; Product Registration; Labeling And Packaging Review; Regulatory Intelligence
3) By Product Design And Development: Formulation Development; Preclinical Development; Bioprocess Development; Analytical Development; Drug Delivery System Design
4) By Auditing And Assessment: Good Manufacturing Practice (GMP) Audits; Good Clinical Practice (GCP) Audits; Quality System Audits; Supplier And Vendor Audits; Risk Assessments
5) By Product Maintenance: Lifecycle Management; Change Management; Technical Support; Software And IT System Updates; Compliance Monitoring
6) By Training And Education: Regulatory Training; Good Laboratory Practice (GLP) Training; Pharmacovigilance Training; Clinical Trial Training; Quality Management Systems Training
7) By Other Services: Intellectual Property Support; Medical Writing; Data Management And Biostatistics; Pharmacovigilance And Drug Safety; Translation And Localization Services
Companies Mentioned: Thermo Fisher Scientific Inc.; Boehringer Ingelheim; LabCorp Holdings; IQVIA Inc.; ICON plc.; Eurofins Scientific SE; Lonza Group Ltd.; Syneos Health; Catalent Inc.; Charles River Laboratories; Samsung Biologics Co. Ltd.; WuXi Biologics; Recipharm AB; Medpace Holdings Inc.; Curia Inc.; CordenPharma Corp.; Parexel International Ltd.; Lachman Consultants; Concept Heidelberg GmbH; The Quantic Group Ltd.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Biotechnology And Pharmaceutical Services Outsourcing Market Characteristics
3. Biotechnology And Pharmaceutical Services Outsourcing Market Trends And Strategies
4. Biotechnology And Pharmaceutical Services Outsourcing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Biotechnology And Pharmaceutical Services Outsourcing Growth Analysis And Strategic Analysis Framework
5.1. Global Biotechnology And Pharmaceutical Services Outsourcing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Biotechnology And Pharmaceutical Services Outsourcing Market Growth Rate Analysis
5.4. Global Biotechnology And Pharmaceutical Services Outsourcing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Biotechnology And Pharmaceutical Services Outsourcing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Biotechnology And Pharmaceutical Services Outsourcing Total Addressable Market (TAM)
6. Biotechnology And Pharmaceutical Services Outsourcing Market Segmentation
6.1. Global Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Consulting
Regulatory Affairs
Product Design And Development
Auditing And Assessment
Product Maintenance
Training And Education
Other Services
6.2. Global Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oncology
Neurology
Cardiovascular
Infectious Diseases
6.3. Global Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pharma
Biotech
6.4. Global Biotechnology And Pharmaceutical Services Outsourcing Market, Sub-Segmentation Of Consulting, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Strategic Consulting
Market Access Consulting
Commercialization Strategy
Portfolio Management
Technology and Digital Transformation Consulting
6.5. Global Biotechnology And Pharmaceutical Services Outsourcing Market, Sub-Segmentation Of Regulatory Affairs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Regulatory Submissions
Compliance and Risk Management
Product Registration
Labeling and Packaging Review
Regulatory Intelligence
6.6. Global Biotechnology And Pharmaceutical Services Outsourcing Market, Sub-Segmentation Of Product Design and Development, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Formulation Development
Preclinical Development
Bioprocess Development
Analytical Development
Drug Delivery System Design
6.7. Global Biotechnology And Pharmaceutical Services Outsourcing Market, Sub-Segmentation Of Auditing and Assessment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Good Manufacturing Practice (GMP) Audits
Good Clinical Practice (GCP) Audits
Quality System Audits
Supplier and Vendor Audits
Risk Assessments
6.8. Global Biotechnology And Pharmaceutical Services Outsourcing Market, Sub-Segmentation Of Product Maintenance, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Lifecycle Management
Change Management
Technical Support
Software and IT System Updates
Compliance Monitoring
6.9. Global Biotechnology And Pharmaceutical Services Outsourcing Market, Sub-Segmentation Of Training and Education, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Regulatory Training
Good Laboratory Practice (GLP) Training
Pharmacovigilance Training
Clinical Trial Training
Quality Management Systems Training
6.10. Global Biotechnology And Pharmaceutical Services Outsourcing Market, Sub-Segmentation Of Other Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Intellectual Property Support
Medical Writing
Data Management and Biostatistics
Pharmacovigilance and Drug Safety
Translation and Localization Services
7. Biotechnology And Pharmaceutical Services Outsourcing Market Regional And Country Analysis
7.1. Global Biotechnology And Pharmaceutical Services Outsourcing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Biotechnology And Pharmaceutical Services Outsourcing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Biotechnology And Pharmaceutical Services Outsourcing Market
8.1. Asia-Pacific Biotechnology And Pharmaceutical Services Outsourcing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Biotechnology And Pharmaceutical Services Outsourcing Market
9.1. China Biotechnology And Pharmaceutical Services Outsourcing Market Overview
9.2. China Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Biotechnology And Pharmaceutical Services Outsourcing Market
10.1. India Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Biotechnology And Pharmaceutical Services Outsourcing Market
11.1. Japan Biotechnology And Pharmaceutical Services Outsourcing Market Overview
11.2. Japan Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Biotechnology And Pharmaceutical Services Outsourcing Market
12.1. Australia Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Biotechnology And Pharmaceutical Services Outsourcing Market
13.1. Indonesia Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Biotechnology And Pharmaceutical Services Outsourcing Market
14.1. South Korea Biotechnology And Pharmaceutical Services Outsourcing Market Overview
14.2. South Korea Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Biotechnology And Pharmaceutical Services Outsourcing Market
15.1. Western Europe Biotechnology And Pharmaceutical Services Outsourcing Market Overview
15.2. Western Europe Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Biotechnology And Pharmaceutical Services Outsourcing Market
16.1. UK Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Biotechnology And Pharmaceutical Services Outsourcing Market
17.1. Germany Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Biotechnology And Pharmaceutical Services Outsourcing Market
18.1. France Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Biotechnology And Pharmaceutical Services Outsourcing Market
19.1. Italy Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Biotechnology And Pharmaceutical Services Outsourcing Market
20.1. Spain Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Biotechnology And Pharmaceutical Services Outsourcing Market
21.1. Eastern Europe Biotechnology And Pharmaceutical Services Outsourcing Market Overview
21.2. Eastern Europe Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Biotechnology And Pharmaceutical Services Outsourcing Market
22.1. Russia Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Biotechnology And Pharmaceutical Services Outsourcing Market
23.1. North America Biotechnology And Pharmaceutical Services Outsourcing Market Overview
23.2. North America Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Biotechnology And Pharmaceutical Services Outsourcing Market
24.1. USA Biotechnology And Pharmaceutical Services Outsourcing Market Overview
24.2. USA Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Biotechnology And Pharmaceutical Services Outsourcing Market
25.1. Canada Biotechnology And Pharmaceutical Services Outsourcing Market Overview
25.2. Canada Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Biotechnology And Pharmaceutical Services Outsourcing Market
26.1. South America Biotechnology And Pharmaceutical Services Outsourcing Market Overview
26.2. South America Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Biotechnology And Pharmaceutical Services Outsourcing Market
27.1. Brazil Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Biotechnology And Pharmaceutical Services Outsourcing Market
28.1. Middle East Biotechnology And Pharmaceutical Services Outsourcing Market Overview
28.2. Middle East Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Biotechnology And Pharmaceutical Services Outsourcing Market
29.1. Africa Biotechnology And Pharmaceutical Services Outsourcing Market Overview
29.2. Africa Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Biotechnology And Pharmaceutical Services Outsourcing Market Competitive Landscape And Company Profiles
30.1. Biotechnology And Pharmaceutical Services Outsourcing Market Competitive Landscape
30.2. Biotechnology And Pharmaceutical Services Outsourcing Market Company Profiles
30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Boehringer Ingelheim Overview, Products and Services, Strategy and Financial Analysis
30.2.3. LabCorp Holdings Overview, Products and Services, Strategy and Financial Analysis
30.2.4. IQVIA Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.5. ICON plc. Overview, Products and Services, Strategy and Financial Analysis
31. Biotechnology And Pharmaceutical Services Outsourcing Market Other Major And Innovative Companies
31.1. Eurofins Scientific SE
31.2. Lonza Group Ltd.
31.3. Syneos Health
31.4. Catalent Inc.
31.5. Charles River Laboratories
31.6. Samsung Biologics Co. Ltd.
31.7. WuXi Biologics
31.8. Recipharm AB
31.9. Medpace Holdings Inc.
31.10. Curia Inc.
31.11. CordenPharma Corp.
31.12. Parexel International Ltd.
31.13. Lachman Consultants
31.14. Concept Heidelberg GmbH
31.15. The Quantic Group Ltd.
32. Global Biotechnology And Pharmaceutical Services Outsourcing Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Biotechnology And Pharmaceutical Services Outsourcing Market
34. Recent Developments In The Biotechnology And Pharmaceutical Services Outsourcing Market
35. Biotechnology And Pharmaceutical Services Outsourcing Market High Potential Countries, Segments and Strategies
35.1 Biotechnology And Pharmaceutical Services Outsourcing Market In 2029 - Countries Offering Most New Opportunities
35.2 Biotechnology And Pharmaceutical Services Outsourcing Market In 2029 - Segments Offering Most New Opportunities
35.3 Biotechnology And Pharmaceutical Services Outsourcing Market In 2029 - Growth Strategies
